Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yee

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|October 8, 2019
Thickness-to-Height Ratio of Intravesical Prostatic Protrusion Predicts the Clinical Outcome and Morbidity of Prostatic Artery Embolization for Benign Prostatic HyperplasiaSimon C H Yu, Carmen C M Cho, Esther H Y Hung, et al.
The Lancet. Neurology|April 13, 2012
Prediction of potential for organ donation after cardiac death in patients in neurocritical state: a prospective observational studyAlejandro A Rabinstein, Alan H Yee, Jay Mandrekar, et al.
Brain Hemorrhages|March 20, 2023
Gene expression changes implicate specific peripheral immune responses to Deep and Lobar Intracerebral Hemorrhages in humansBodie Knepp, Bradley P Ander, Glen C Jickling, et al.
Leukemia|September 23, 2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)M M Schittenhelm, K W H Yee, J W Tyner, et al.
Current Pharmaceutical Design|March 17, 2020
Current Status and Challenges in Rotigotine DeliveryShadab Md, Shahid Karim, Sanggetha R Saker, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 5, 2020
Patient-reported outcomes after surgery or radiotherapy for localised prostate cancer: a retrospective studyC F Ng, K Y Kong, C Y Li, et al.
Canadian Journal of Physiology and Pharmacology|October 2, 2018
Sustained quality improvement in outcomes of preterm neonates with a gestational age less than 29 weeks: results from the Evidence-based Practice for Improving Quality Phase 3 <sup>1</sup>Prakesh S Shah, Michael Dunn, Khalid Aziz, et al.
JAMA Network Open|July 22, 2020
Association of Gender and Race With Allocation of Advanced Heart Failure TherapiesKhadijah Breathett, Erika Yee, Natalie Pool, et al.
Arthroplasty (London, England)|September 1, 2024
Reliability of pre-resection ligament tension assessment in imageless robotic assisted total knee replacementDennis K H Yee, Jonathan T C Leung, Vikki Chu, et al.
Blood|January 18, 2003
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoAnne-Marie O'Farrell, Tinya J Abrams, Helene A Yuen, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Journal of Vascular and Interventional Radiology : JVIR|October 8, 2019
Thickness-to-Height Ratio of Intravesical Prostatic Protrusion Predicts the Clinical Outcome and Morbidity of Prostatic Artery Embolization for Benign Prostatic HyperplasiaSimon C H Yu, Carmen C M Cho, Esther H Y Hung, et al.
The Lancet. Neurology|April 13, 2012
Prediction of potential for organ donation after cardiac death in patients in neurocritical state: a prospective observational studyAlejandro A Rabinstein, Alan H Yee, Jay Mandrekar, et al.
Brain Hemorrhages|March 20, 2023
Gene expression changes implicate specific peripheral immune responses to Deep and Lobar Intracerebral Hemorrhages in humansBodie Knepp, Bradley P Ander, Glen C Jickling, et al.
Leukemia|September 23, 2006
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248)M M Schittenhelm, K W H Yee, J W Tyner, et al.
Current Pharmaceutical Design|March 17, 2020
Current Status and Challenges in Rotigotine DeliveryShadab Md, Shahid Karim, Sanggetha R Saker, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 5, 2020
Patient-reported outcomes after surgery or radiotherapy for localised prostate cancer: a retrospective studyC F Ng, K Y Kong, C Y Li, et al.
Canadian Journal of Physiology and Pharmacology|October 2, 2018
Sustained quality improvement in outcomes of preterm neonates with a gestational age less than 29 weeks: results from the Evidence-based Practice for Improving Quality Phase 3 <sup>1</sup>Prakesh S Shah, Michael Dunn, Khalid Aziz, et al.
JAMA Network Open|July 22, 2020
Association of Gender and Race With Allocation of Advanced Heart Failure TherapiesKhadijah Breathett, Erika Yee, Natalie Pool, et al.
Arthroplasty (London, England)|September 1, 2024
Reliability of pre-resection ligament tension assessment in imageless robotic assisted total knee replacementDennis K H Yee, Jonathan T C Leung, Vikki Chu, et al.
Blood|January 18, 2003
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoAnne-Marie O'Farrell, Tinya J Abrams, Helene A Yuen, et al.
Pageof 22